Glucose 6-phosphate dehydrogenase deficient subjects may be better “storers” than donors of red blood cells
Vassilis L. Tzounakas(University of Patras), Marianna H. Antonelou(National and Kapodistrian University of Athens), Travis Nemkov(University of Colorado Anschutz Medical Campus), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Hara Τ. Georgatzakou, Matthew J. Wither(University of Colorado Denver), Kirk C. Hansen(University of Colorado Anschutz Medical Campus), Anastasios G. Kriebardis(University of West Attica), Monika Dzieciątkowska(University of Colorado Anschutz Medical Campus), Issidora S. Papassideri(National and Kapodistrian University of Athens), Leontini E. Foudoulaki‐Paparizos(General Hospital of Nikea)
Cited by 115
Related Papers
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
|JCI Insight|2020|600
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
|Cancer Cell|2018|565
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556